The Holmes documentary is out. Conservative media hasn't noticed.
A24 released 'You Can See Everything,' a Nathan Fielder and Lance Oppenheim documentary about Elizabeth Holmes, and the coverage so far is two center-left outlets processing their own susceptibility to her story. Business Insider's reviewer admitted wanting to believe her. Fast Company is selling desk access. Right-leaning outlets, which spent years covering Theranos as a cautionary tale about Silicon Valley hype, are nowhere in this cycle.
Elizabeth Holmes documentary sparks renewed interest in Theranos scandal
2 sources · hover a dot to see coverage
What happened
A24's documentary 'You Can See Everything,' directed by Nathan Fielder and Lance Oppenheim, is now in theaters. It centers on Elizabeth Holmes, the Theranos founder convicted in 2022 on four counts of fraud and currently serving an 11-year federal prison sentence. The film arrives roughly four years after Holmes's trial and two years into her incarceration. Business Insider published a first-person review describing the film as unsettling precisely because of how effectively Holmes's self-presentation still lands. Fast Company tied its coverage to a novelty angle: a replica of Holmes's desk is now available for purchase. That is the wire version. Two outlets have it, both center-left, and the asymmetry in who is and isn't covering the documentary's release is the more interesting story.
Center-left outlets turned the review into a confession
Business Insider's review doesn't evaluate the film so much as document the reviewer's discomfort at finding Holmes persuasive on screen. That framing, 'the scariest thing is how much I wanted to believe her,' is a specific editorial choice: it makes the audience's credulity the subject rather than Holmes's conduct or the film's craft. Fast Company skipped the film's argument entirely and ran with the desk. A replica of Holmes's Theranos workspace is being sold, and Fast Company treated that as the news peg. Both pieces are more interested in the cultural residue of the Holmes story than in the documentary's actual claims.
What one side told you that the other didn't
Right-leaning outlets covered the trial. They skipped the documentary.
Theranos and Holmes were reliable copy for conservative and right-leaning outlets during the trial years, fitting a clean narrative about Silicon Valley fraud and media credulity toward a female founder. The documentary, directed by Nathan Fielder, is exactly the kind of cultural artifact that invites that critique again. None of those outlets appear in this coverage cycle. Whether that reflects weekend editorial bandwidth, a documentary beat they don't staff, or simple disinterest, the gap means the only published takes right now are from outlets whose reviewers are examining their own susceptibility rather than the systemic failures the story exposed.
Nobody has reviewed what the documentary actually argues.
Two pieces, zero film criticism in the traditional sense. Business Insider reviewed the reviewer's feelings. Fast Company reviewed a desk. 'You Can See Everything' is a Nathan Fielder project, which means it almost certainly has a formal argument about performance, self-presentation, and the construction of a founder persona. What that argument is, whether it exonerates or indicts, whether it introduces new material, none of that is in the published coverage. A24 is in theaters now and the critical record so far is a mood piece and a furniture story.
What to watch
If broader critical coverage lands in the next 72 hours, watch whether right-leaning outlets engage with the Fielder framing specifically. Fielder's previous work ('The Rehearsal') drew pointed criticism about manipulation and consent. If that conversation surfaces around this film, it is the likeliest entry point for outlets that sat out the initial release cycle.
This kind of gap — where one side reports a fact and the other doesn’t mention it — shows up in about 40% of major stories.